IP Library Granted Patent US 10,611,818
Granted Patent B2
US 10,611,818 · App. 12/680,248 · Granted Apr 7, 2020

MHC multimers in tuberculosis diagnostics, vaccine and therapeutics

Inventors: Jørgen Schøller (Lyngby, DK); Liselotte Brix (Bagsværd, DK); Henrik Pedersen (Lynge, DK); Tina Jakobsen (Ballerup, DK)
Assignee: Agilent Technologies, Inc.
C07K14/70539A61K39/0011A61K39/04A61K39/12A61K39/245A61K47/61A61K47/6425G01N33/56972A61K2039/605A61K2039/6087A61K2039/625C12N2710/16134G01N2333/35G01N2333/70539
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,611,818
App. No.
12/680,248
Granted
Apr 7, 2020
Kind
B2
Abstract

The present invention relates to MHC-peptide complexes and uses thereof in the diagnosis of, treatment of or vaccination against a disease in an individual. More specifically the invention discloses MHC complexes comprising Mycobacterium tuberculosis antigenic peptides and uses there of.

Claims (13)

1. A composition comprising a plurality of soluble MHC multimers wherein, each MHC multimer comprises (a-b-P)n,

wherein n>4,

wherein a and b together form a functional MHC protein capable of binding the peptides P,

wherein (a-b-P) is the MHC-peptide complex formed when the peptide P binds to the functional MHC protein,

wherein each MHC-peptide complex of each MHC multimer is associated with one or more multimerization domains selected from the group consisting of polysaccharides, dextran moieties, coiled-coil polypeptide structures, avidins, streptavidins and antibodies, wherein each MHC protein is an HLA-A*0201 allele, and

wherein the composition comprises at least one multimer wherein each P is SEQ ID NO: 12637, at least one multimer wherein each P is SEQ ID NO: 12603, at least one multimer wherein each P is SEQ ID NO: 12731, at least one multimer wherein each P is SEQ ID NO: 124191, at least one multimer wherein each P is SEQ ID NO: 124224, at least one multimer wherein each P is SEQ ID NO: 124174 and at least one multimer wherein each P is SEQ ID NO: 124187.

2. A kit comprising the composition according to claim 1 .

3. The kit according to claim 2 , comprising at least one additional component.

4. The kit according to claim 3 , wherein the additional component is a positive control.

5. The kit according to claim 3 , wherein the additional component is instructions for use.

6. The composition according to claim 1 , wherein the MHC multimer comprises one or more covalently or non-covalently attached label selected from the group consisting of fluorophores, fluorescent labels, enzyme labels, radioactive labels, chemiluminescent labels, dyes, chromophores, fluorochromes, bioluminescent labels, metal particles, haptens, DNA fluorescing stains, polymers, and antibodies.

7. The composition according to claim 1 , wherein n>10.

8. The composition according to claim 1 , wherein n is between 10 and 20.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2020
From: DAKO DENMARK APS
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 051629/0162 →
CHANGE OF NAME Recorded Jan 27, 2020
From: DAKO DENMARK A/S
To: DAKO DENMARK APS
Reel/Frame 051708/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2011
From: SCHOLLER, JORGEN; BRIX, LISELOTTE; PEDERSEN, HENRIK; JAKOBSEN, TINA
To: DAKO DENMARK A/S
Reel/Frame 025865/0171 →
Priority Claims (1)
DK 2007 01395 · Sep 27, 2007 · national
Continuity (2)
Provisional Application 60960394 · Sep 27, 2007
Related Publication 20110236411A1 · Sep 29, 2011
Cited By (2)
US 12,352,719 US 12,653,872